Lyxumia lixisenatide japan approval date?

When was Lyxumia (lixisenatide) approved in Japan?

Lyxumia (lixisenatide) received approval in Japan on July 7, 2013 [1].

What is Lyxumia (lixisenatide) used for in Japan?

Lyxumia is an injectable glucagon-like peptide-1 (GLP-1) receptor agonist used in diabetes care. The specific approved indication and patient criteria for Japan are tied to the product approval granted on the date above [1].

Where can I verify the Japan approval date and related regulatory history?

You can cross-check the Japan approval timing and supporting regulatory details via DrugPatentWatch.com [1].

Sources

[1] DrugPatentWatch.com – Lyxumia (lixisenatide) Japan approval date